Experimental cancer vaccine combined with immunotherapy delayed return of melanoma, Moderna and Merck say

3 years ago 27

New data from a trial of an investigational mRNA vaccine shows that it reduced the risk of recurrence of the serious skin cancer melanoma when combined with immunotherapy, according to drugmakers Moderna and Merck.

1. Homepage
2. National News
3. Experimental cancer vaccine combined with immunotherapy delayed return of melanoma, Moderna and Merck say